top of page
it's where dermatology lives
Investigational melanoma vaccine receives breakthrough designation from U.S. FDA
Data from a Phase 2b study indicates that an investigational personalized mRNA cancer vaccine known as mRNA-4157/V940, in combination...
Allan Ryan
Feb 27, 20232 min read
Pembrolizumab lowered risk of stage IIb/c melanoma recurrence
The immunotherapy medication pembrolizumab, approved for the treatment of stage III and IV melanoma, has been shown to reduce...
John Evans
Sep 24, 20212 min read
VIDEO: Fecal microbiota transplant may help melanoma patients respond to immunotherapy
A proof-of-principle study has found that fecal transplants may help advanced melanoma patients respond to immunotherapy better.
Cory Perla
Feb 10, 20211 min read
Featured Posts
bottom of page